CNBX Pharmaceuticals Inc. Quarterly Operating Margin in % from Q3 2017 to Q3 2024

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
CNBX Pharmaceuticals Inc. quarterly/annual Operating Margin history and growth rate from Q3 2017 to Q3 2024.
  • CNBX Pharmaceuticals Inc. Operating Margin for the quarter ending August 31, 2024 was -448 %, a 97.4% decline year-over-year.
  • CNBX Pharmaceuticals Inc. annual Operating Margin for 2024 was -448 %, a 97.4% decline from 2023.
  • CNBX Pharmaceuticals Inc. annual Operating Margin for 2023 was -227 %, a 97.7% increase from 2022.
  • CNBX Pharmaceuticals Inc. annual Operating Margin for 2022 was -9.86K %.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -448 -221 -97.4% Jun 1, 2024 Aug 31, 2024
Q2 2024 -301 Mar 1, 2024 May 31, 2024
Q1 2024 -132 Dec 1, 2023 Feb 29, 2024
Q4 2023 -151 Sep 1, 2023 Nov 30, 2023
Q3 2023 -227 Jun 1, 2023 Aug 31, 2023
Q2 2021 -121K -73.3K -153% Mar 1, 2021 May 31, 2021
Q1 2021 -65.7K -18.4K -39% Dec 1, 2020 Feb 28, 2021
Q4 2020 -53.4K -11.6K -27.7% Sep 1, 2020 Nov 30, 2020
Q3 2020 -42.5K -8.96K -26.7% Jun 1, 2020 Aug 31, 2020
Q2 2020 -47.8K -19.5K -68.9% Mar 1, 2020 May 31, 2020
Q1 2020 -47.3K -20.3K -75.1% Dec 1, 2019 Feb 29, 2020
Q4 2019 -41.9K -6.7K -19% Sep 1, 2019 Nov 30, 2019
Q3 2019 -33.6K +6.11K +15.4% Jun 1, 2019 Aug 31, 2019
Q2 2019 -28.3K +15.6K +35.5% Mar 1, 2019 May 31, 2019
Q1 2019 -27K +19.7K +42.2% Dec 1, 2018 Feb 28, 2019
Q4 2018 -35.2K -4.42K -14.4% Sep 1, 2018 Nov 30, 2018
Q3 2018 -39.7K -7.05K -21.6% Jun 1, 2018 Aug 31, 2018
Q2 2018 -43.9K Mar 1, 2018 May 31, 2018
Q1 2018 -46.7K Dec 1, 2017 Feb 28, 2018
Q4 2017 -30.7K Sep 1, 2017 Nov 30, 2017
Q3 2017 -32.6K Jun 1, 2017 Aug 31, 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.